MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
AFYA stock logo

AFYA

Afya Limited

$14.38
-0.06
 (-0.42%)
Exchange:  NASDAQ
Market Cap:  1.298B
Shares Outstanding:  87.683M
Delayed data
Calculate AFYA Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Consumer Defensive
Industry:  Education & Training Services
   
CEO:  Virgilio Deloy Capobianco Gibbon
Full Time Employees:  5260
Address: 
Alameda Oscar Niemeyer, No. 119
Nova Lima
MG
BR
Website:  https://www.afya.com.br
Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya’s educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/10 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,875,9133,304,3293,624,629.082
Gross Profit1,766,1002,088,7262,336,543.183
EBITDA1,105,3891,218,0231,189,373.769
Operating Income767,0611,012,1131,189,373.769
Net Income386,324631,510737,680.255

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets7,584,4818,829,5399,353,237.741
Total Liabilities3,941,4694,518,9564,464,507.370
Total Stockholders Equity3,601,5054,269,9554,849,361.136
Total Debt2,675,3443,173,4973,118,447.223
Cash and Cash Equivalents553,030911,0151,124,816.227

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow1,043,6231,432,6591,199,238.119
Capital Expenditure-245,428-136,924-162,752.949
Free Cash Flow798,1951,295,7351,036,485.170
Net Income429,582631,510737,680.255
Net Change in Cash-540,052357,985317,151.890

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)4,456,058.231Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)4,677,155.612Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)4,548,670.928Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)1,631,719.756Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)1,712,681.213Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)1,665,632.681Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)826,490.288Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)1,090,798.554Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)958,644.421Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,512,560.376Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,587,609.471Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,543,996.746Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)10.950Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)11.950Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)9.060Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)5Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)3Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
612.94M  ?P/S
 (TTM)
: 
1.79
?Net Income
 (TTM)
: 
117.143M  ?P/E
 (TTM)
: 
8.84
?Enterprise Value
 (TTM)
: 
8.585B  ?EV/FCF
 (TTM)
: 
7.37
?Dividend Yield
 (TTM)
: 
0.05  ?Payout Ratio
 (TTM)
: 
0.02
?ROE
 (TTM)
: 
0.16  ?ROIC
 (TTM)
: 
0.13
?Net Debt
 (TTM)
: 
366.225M  ?Debt/Equity
 (TTM)
: 
0.67
?P/B
 (TTM)
: 
1.42  ?Current Ratio
 (TTM)
: 
1.78

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
6.58Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates AFYA intrinsic value between $76.29 – $209.16 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about AFYA valuation

Is Afya Limited (AFYA) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Afya Limited (AFYA) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is AFYA a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether AFYA trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is AFYA’s P/E ratio?

You can see AFYA’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for AFYA?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is AFYA a good long-term investment?

Whether AFYA fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

AFYA

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.42
MARKETSnap

Trading Metrics:

Open: 14.55   Previous Close: 14.44
Day Low: 14.25   Day High: 14.68
Year Low: 13   Year High: 18.53
Price Avg 50: 14.55   Price Avg 200: 14.72
Volume: 79826   Average Volume: 95315

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Afya Limited (the "Company") Notice of Annual General Meeting of the Company
02-06-2026 17:56
Afya Limited (the "Company") Notice of Annual General Meeting of the Company
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know
25-05-2026 10:56
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know
AFYA or APEI: Which Is the Better Value Stock Right Now?
04-05-2026 12:40
AFYA or APEI: Which Is the Better Value Stock Right Now?
Afya Limited (AFYA) Q1 2026 Earnings Call Transcript
07-05-2026 23:51
Afya Limited (AFYA) Q1 2026 Earnings Call Transcript
Afya Limited Announces First-Quarter 2026 Financial Results
07-05-2026 20:42
Afya Limited Announces First-Quarter 2026 Financial Results
AFYA vs. LOPE: Which Stock Is the Better Value Option?
16-03-2026 12:40
AFYA vs. LOPE: Which Stock Is the Better Value Option?

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read